$73.00
1.351.88%
Last update: Nov 5, 9:30 AM
ANI Pharmaceuticals Inc
ANIPNASDAQ
The average analyst price target for ANI Pharmaceuticals is $93.75, 28.4% above the current price. Of 11 analysts, 9 rate it Buy and 2 Hold. Targets range from $68 to $121. The latest change came on Sep 23, 2026, when Oppenheimer initiated coverage of ANI Pharmaceuticals with a Perform rating and a $85 price target.
Price Target Range — 10 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
